InSysBio to take part in AACR Virtual Annual Meeting II

events
May 15, 2020

May 15, 2020

InSysBio announces its participation in AACR Virtual Annual Meeting II June 22-24, American Association for Cancer Research Annual Meeting which is held virtually this year due to COVID-19 spread. Today InSysBio team’s abstracts were published on AACR website, namely:

(Session PO.IM02.10 - Immune Checkpoints 2)

(Session PO.BSB02.02 - Mathematical Modeling)

Posters are going to be published on June 22, 2020, 9:00 AM

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

June 2025
MoTuWeThFrSaSu
      
1
2
3
1. 03 Jun 2025 20:43 InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling InSysBio releases an integration of CYTOCON DB and fIVE DB with Heta. Now Heta format is upgraded to allow direct query to databases from the QSP model code without working with database websites.
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
1. 18 Jun 2025 18:30 InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology The new article “Quantitative Systems Pharmacology Model That Describes Neurofilament Light Dynamics During Alzheimer's Disease Progression” by Polina Maliukova, Tatiana Karelina was published in CPT: Pharmacometrics & Systems Pharmacology Journal on June 17, 2025
19
20
21
22
23
24
25
1. 25 Jun 2025 14:32 The project aims at translational mechanistic modeling of antibodies to predict human pharmacokinetics and target occupancy in cerebrospinal fluid InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the extension of collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer’s Disease.
26
27
28
29
30
      
Upcoming Events
Tags
Latest News
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling
30.05
InSysBio to publish the new article in CPT: Clinical Pharmacology & Therapeutics
15.05
15th InSysBio’s Annual Internal Scientific Meeting